Gateway to China

Jul 16, 2019

The drug regulatory authority of China – National Medical Product Administration (NMPA, formerly CFDA) has recently implemented a possibility to report Adverse Drug Reactions (ADR) through an XML-file submission. Flex Databases Pharmacovigilance system users are already able to do so.

There are two general ways of reporting to the regulator – manual submissions through the website and automated gateway submissions. To submit files manually, the company has to register on the Center for Drug Evaluation (CDE) website and get a login and password for a personal cabinet through an Applicant Window.

There is the second way – direct submissions to the regulator’s database through the gateway. To establish the connection between two databases the company must exchange the set of settings with the regulator and test it carefully. After the configuration is done, the company can submit XML-files directly to the reporting system, with minimal user effort involved.

Gateway submission method is the one, preferablе by the regulator. It works faster and ensures a higher level of data security and integrity – the human factor is not affecting the file during its processing between two databases. In the case of highly sensitive data, which ADRs are, it’s a major advantage. Gateway method supposes that the sender receives the acknowledgment receipt from the regulator. This receipt may contain information about submission success or reject as well as the listing of errors detected.

Both methods of submission require XML files, compliant to E2B R3, and our system is fully compliant to the format.

Flex Databases had successfully tested both methods. Automated submission is now added as a feature to our Pharmacovigilance system – and our customers are welcome to use it to submit files and check submission statuses. We also provide a possibility to export an XML file from the system for the manual submission through the CDE website.

More about Pharmacovigilance

Manage multi-lingual cases within a single
Manage multi-lingual cases within a single instance with Flex Databases Pharmacovigilance

With Flex Databases Pharmacovigilance, you’ll only need one case, and you can add as many languages to it as you want.

Learn more
Three big questions AI helps to answer in drug development process
Three big questions AI helps to answer in drug development process

By automating processes, reducing human error, and improving decision-making, AI can help make clinical trials more efficient, effective, and safe.

Learn more
Clinergy Health Research selects Flex Databases Pharmacovigilance
Clinergy Health Research selects Flex Databases Pharmacovigilance as cost-effective and easy to integrate solution

Clinergy Health Research selects Flex Databases Pharmacovigilance as cost-effective and easy to integrate solution

Learn more
Flex Databases recognised as one of top-10 Pharmacovigilance providers in the UK & Europe -2
Flex Databases recognised as one of top-10 Pharmacovigilance providers in the UK & Europe

This September, Pharma Tech Outlook included Flex Databases in Top-10 Pharmacovigilance solutions providers in the UK & Europe.

Learn more

Get in touch to discuss compliance, implementation, demos, pricing

We are here for all of your questions! Tell us more about yourself and we will organize a tailored live demo to show how you can power up your clinical trials processes with Flex Databases.